{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:20:12Z","timestamp":1771305612988,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1124\/jpet.105.091587","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T04:48:32Z","timestamp":1137646112000},"page":"1300-1309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Tibolone Metabolism in Human Liver Is Catalyzed by 3\u03b1\/3\u03b2-Hydroxysteroid Dehydrogenase Activities of the Four Isoforms of the Aldo-Keto Reductase (AKR)1C Subfamily"],"prefix":"10.1016","volume":"316","author":[{"given":"Stephan","family":"Steckelbroeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Busola","family":"Oyesanmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon-Hwa","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helenius J.","family":"Kloosterboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor M.","family":"Penning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.091587_bib1","doi-asserted-by":"crossref","unstructured":"Albertazzi P, di Micco R, and Zanardi E (1998) Tibolone: a review. Maturitas 30: 295\u2013305.","DOI":"10.1016\/S0378-5122(98)00059-0"},{"key":"10.1124\/jpet.105.091587_bib2","doi-asserted-by":"crossref","unstructured":"Biswas MG and Russell DW (1997) Expression cloning and characterization of oxidative 17\u03b2- and 3\u03b1-hydroxysteroid dehydrogenases from rat and human prostate. J Biol Chem 272: 15959\u201315966.","DOI":"10.1074\/jbc.272.25.15959"},{"key":"10.1124\/jpet.105.091587_bib3","doi-asserted-by":"crossref","unstructured":"Blok LJ, De Ruiter PE, Kuhne EC, Hanekamp EE, Grootegoed JA, Smid-Koopman E, Gielen SC, De Gooyer ME, Kloosterboer HJ, and Burger CW (2003) Progestogenic effects of tibolone on human endometrial cancer cells. J Clin Endocrinol Metab 88: 2327\u20132334.","DOI":"10.1210\/jc.2002-021737"},{"key":"10.1124\/jpet.105.091587_bib4","unstructured":"Blom MJ (2001) Steroids and steroid analogues for hormone replacement therapy: metabolism in target tissues. Ph.D. dissertation, University of Utrecht, Utrecht, The Netherlands."},{"key":"10.1124\/jpet.105.091587_bib5","doi-asserted-by":"crossref","unstructured":"Burczynski ME, Harvey RG, and Penning TM (1998) Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. Biochemistry 37: 6781\u20136790.","DOI":"10.1021\/bi972725u"},{"key":"10.1124\/jpet.105.091587_bib6","doi-asserted-by":"crossref","unstructured":"Chetyrkin SV, Hu J, Gough WH, Dumaual N, and Kedishvili NY (2001) Further characterization of human microsomal 3\u03b1-hydroxysteroid dehydrogenase. Arch Biochem Biophys 386: 1\u201310.","DOI":"10.1006\/abbi.2000.2203"},{"key":"10.1124\/jpet.105.091587_bib7","doi-asserted-by":"crossref","unstructured":"Chetrite GS, Kloosterboer HJ, Philippe JC, and Pasqualini JR (1999) Effects of Org OD14 (Livial) and its metabolites on 17\u03b2-hydroxysteroid dehydrogenase activity in hormone dependent MCF-7 and T-47D breast cancer cells. Anticancer Res 19: 261\u2013267.","DOI":"10.1016\/S0960-0760(98)00163-0"},{"key":"10.1124\/jpet.105.091587_bib8","doi-asserted-by":"crossref","unstructured":"Colacurci N, Mele D, De Franciscis P, Costa V, Fortunato N, and De Seta L (1998) Effects of tibolone on the breast. Eur J Obstet Gynecol Reprod Biol 80: 235\u2013238.","DOI":"10.1016\/S0301-2115(98)00129-8"},{"key":"10.1124\/jpet.105.091587_bib9","doi-asserted-by":"crossref","unstructured":"Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA, and Runge-Morris M (2002) Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 30: 997\u20131004.","DOI":"10.1124\/dmd.30.9.997"},{"key":"10.1124\/jpet.105.091587_bib10","doi-asserted-by":"crossref","unstructured":"de Gooyer ME, Deckers GH, Schoonen WGEJ, Verheul HAM, and Kloosterboer HJ (2003) Receptor profiling and endocrine interactions of tibolone. Steroids 68: 21\u201330.","DOI":"10.1016\/S0039-128X(02)00112-5"},{"key":"10.1124\/jpet.105.091587_bib11","doi-asserted-by":"crossref","unstructured":"de Gooyer ME, Kleyn GT, Smits KC, Ederveen AG, Verheul HA, and Kloosterboer HJ (2001) Tibolone: a compound with tissue specific inhibitory effects on sulfatase. Mol Cell Endocrinol 183: 55\u201362.","DOI":"10.1016\/S0303-7207(01)00606-2"},{"key":"10.1124\/jpet.105.091587_bib12","doi-asserted-by":"crossref","unstructured":"Falany JL, Macrina N, and Falany CN (2004) Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 88: 383\u2013391.","DOI":"10.1016\/j.jsbmb.2004.01.005"},{"key":"10.1124\/jpet.105.091587_bib13","doi-asserted-by":"crossref","unstructured":"Gompel A, Chaouat M, Jacob D, Perrot JY, Kloosterboer HJ, and Rostene W (2002) In vitro studies of tibolone in breast cells. Fertil Steril 78: 351\u2013359.","DOI":"10.1016\/S0015-0282(02)03203-X"},{"key":"10.1124\/jpet.105.091587_bib14","doi-asserted-by":"crossref","unstructured":"Gough WH, VanOoteghem S, Sint T, and Kedishvili NY (1998) cDNA cloning and characterization of a new human microsomal NAD+-dependent dehydrogenase that oxidizes all-trans- retinol and 3\u03b1-hydroxysteroids. J Biol Chem 273: 19778\u201319785.","DOI":"10.1074\/jbc.273.31.19778"},{"key":"10.1124\/jpet.105.091587_bib15","doi-asserted-by":"crossref","unstructured":"He XY, Yang YZ, Peehl DM, Lauderdale A, Schulz H, and Yang SY (2003) Oxidative 3\u03b1-hydroxysteroid dehydrogenase activity of human type 10 17\u03b2-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 87: 191\u2013198.","DOI":"10.1016\/j.jsbmb.2003.07.007"},{"key":"10.1124\/jpet.105.091587_bib16","doi-asserted-by":"crossref","unstructured":"He XY, Yang YZ, Schulz H, and Yang SY (2000) Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase. Biochem J 345: 139\u2013143.","DOI":"10.1042\/bj3450139"},{"key":"10.1124\/jpet.105.091587_bib17","doi-asserted-by":"crossref","unstructured":"Higaki Y, Usami N, Shintani S, Ishikura S, El-Kabbani O, and Hara A (2003) Selective and potent inhibitors of human 20\u03b1-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone. Chem Biol Interact 143\u2013144: 503\u2013513.","DOI":"10.1016\/S0009-2797(02)00206-5"},{"key":"10.1124\/jpet.105.091587_bib18","doi-asserted-by":"crossref","unstructured":"Kloosterboer HJ (2001) Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76: 231\u2013238.","DOI":"10.1016\/S0960-0760(01)00044-9"},{"key":"10.1124\/jpet.105.091587_bib19","doi-asserted-by":"crossref","unstructured":"Kloosterboer HJ and Ederveen AGH (2003) Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMS and estrogen (+\/\u2013progestogen) treatments. J Steroid Biochem Mol Biol 83: 157\u2013165.","DOI":"10.1016\/S0960-0760(03)00055-4"},{"key":"10.1124\/jpet.105.091587_bib20","doi-asserted-by":"crossref","unstructured":"Liden M, Tryggvason K, and Eriksson U (2003) Structure and function of retinol dehydrogenases of the short chain dehydrogenase\/reductase family. Mol Aspects Med 24: 403\u2013409.","DOI":"10.1016\/S0098-2997(03)00036-0"},{"key":"10.1124\/jpet.105.091587_bib21","unstructured":"Moore RA (1999) Livial: a review of clinical studies. Br J Obstet Gynaecol 106 (Suppl. 19): 1\u201321."},{"key":"10.1124\/jpet.105.091587_bib22","doi-asserted-by":"crossref","unstructured":"Narasaka T, Moriya T, Endoh M, Suzuki T, Shizawa S, Mizokami Y, Matsuoka T, and Sasano H (2000) 17\u03b2-Hydroxysteroid dehydrogenase type 2 and dehydroepiandrosterone sulfotransferase in the human liver. Endocr J 47: 697\u2013705.","DOI":"10.1507\/endocrj.47.697"},{"key":"10.1124\/jpet.105.091587_bib23","doi-asserted-by":"crossref","unstructured":"Pasqualini JR and Chetrite GS (1999) Estrone sulfatase versus estrone sulfotransferase in human breast cancer: potential clinical applications. J Steroid Biochem Mol Biol 59: 287\u2013292.","DOI":"10.1016\/S0960-0760(99)00082-5"},{"key":"10.1124\/jpet.105.091587_bib24","doi-asserted-by":"crossref","unstructured":"Penning TM (1997) Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev 18: 281\u2013305.","DOI":"10.1210\/edrv.18.3.0302"},{"key":"10.1124\/jpet.105.091587_bib25","doi-asserted-by":"crossref","unstructured":"Penning TM, Burczynski ME, Jez JM, Hung C-F, Lin H-K, Ma H, Moore M, Palackal N, and Ratnam K (2000) Human 3\u03b1-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351: 67\u201377.","DOI":"10.1042\/bj3510067"},{"key":"10.1124\/jpet.105.091587_bib26","doi-asserted-by":"crossref","unstructured":"Perera SK, Dunn WA, and Fedor LR (1980) Acid- and base-catalyzed isomerization of androst-5-ene-3,17-dione and 17\u03b1-ethynyl-17\u03b2-hydroxy-5(10)-estren-3-one. J Org Chem 45: 2816\u20132821.","DOI":"10.1021\/jo01302a013"},{"key":"10.1124\/jpet.105.091587_bib27","doi-asserted-by":"crossref","unstructured":"Purohit A, Malini B, Hooymans C, and Newman SP (2001) Inhibition of oestrone sulphatase activity by tibolone and its metabolites. Horm Metab Res 34: 1\u20136.","DOI":"10.1055\/s-2002-19958"},{"key":"10.1124\/jpet.105.091587_bib28","doi-asserted-by":"crossref","unstructured":"Ri\u017ener T, Lin HK, Peehl DM, Steckelbroeck S, Bauman DR, and Penning TM (2003) Human type 3 3\u03b1-hydroxysteroid dehydrogenase (AKR1C2) and androgen metabolism in prostate cells. Endocrinology 144: 2922\u20132932.","DOI":"10.1210\/en.2002-0032"},{"key":"10.1124\/jpet.105.091587_bib29","doi-asserted-by":"crossref","unstructured":"Sandker GW, Vos RM, Delbressine LP, Slooff MJ, Meijer DK, and Groothuis GM (1994) Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison of metabolism in vivo. Xenobiotica 24: 143\u2013155.","DOI":"10.3109\/00498259409043228"},{"key":"10.1124\/jpet.105.091587_bib30","doi-asserted-by":"crossref","unstructured":"Smith CL and O\u2019Malley BW (2004) Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25: 45\u201371.","DOI":"10.1210\/er.2003-0023"},{"key":"10.1124\/jpet.105.091587_bib31","doi-asserted-by":"crossref","unstructured":"Song WC, Qian Y, and Li AP (1998) Estrogen sulfotransferase expression in the human liver: marked interindividual variation and lack of gender specificity. J Pharmacol Exp Ther 284: 1197\u20131202.","DOI":"10.1016\/S0022-3565(24)37332-X"},{"key":"10.1124\/jpet.105.091587_bib32","doi-asserted-by":"crossref","unstructured":"Steckelbroeck S, Jin Y, Gopishetty S, Oyesanmi B, and Penning TM (2004a) Human cytosolic 3\u03b1-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3\u03b2-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J Biol Chem 279: 10784\u201310795.","DOI":"10.1074\/jbc.M313308200"},{"key":"10.1124\/jpet.105.091587_bib33","doi-asserted-by":"crossref","unstructured":"Steckelbroeck S, Jin Y, Oyesanmi B, Kloosterboer HJ, and Penning TM (2004b) Tibolone is metabolized by the 3\u03b1\/3\u03b2-hydroxysteroid dehydrogenase (HSD) activities of the four human isozymes of the aldo-keto reductase (AKR)1C subfamily: inversion of stereospecificity with a \u03945(10)-3-ketosteroid. Mol Pharmacol 66: 1702\u20131711.","DOI":"10.1124\/mol.104.004515"},{"key":"10.1124\/jpet.105.091587_bib34","doi-asserted-by":"crossref","unstructured":"Stoffel-Wagner B, Watzka M, Steckelbroeck S, Ludwig M, Clusmann H, Bidlingmaier F, Casarosa E, Luisi S, Elger CE, and Beyenburg S (2003) Allopregnanolone serum levels and expression of 5\u03b1-reductase and 3\u03b1-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res 54: 11\u201319.","DOI":"10.1016\/S0920-1211(03)00036-6"},{"key":"10.1124\/jpet.105.091587_bib35","doi-asserted-by":"crossref","unstructured":"Timmer CJ, Verheul HAM, and Doorstam DP (2002) Pharmacokinetics of tibolone in early and late postmenopausal women. J Clin Pharmacol 54: 101\u2013106.","DOI":"10.1046\/j.1365-2125.2002.01619.x"},{"key":"10.1124\/jpet.105.091587_bib36","doi-asserted-by":"crossref","unstructured":"van de Ven J, Donker GH, Sprong M, Blankenstein MA, and Thijssen JH (2002) Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells. J Steroid Biochem Mol Biol 81: 237\u2013247.","DOI":"10.1016\/S0960-0760(02)00068-7"},{"key":"10.1124\/jpet.105.091587_bib37","doi-asserted-by":"crossref","unstructured":"Valdivia I and Ortega D (2000) Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clin Drug Investig 20: 101\u2013107.","DOI":"10.2165\/00044011-200020020-00005"},{"key":"10.1124\/jpet.105.091587_bib38","doi-asserted-by":"crossref","unstructured":"Volker W, Coelingh Bennink HJ, and Helmond FA (2001) Effects of tibolone on the endometrium. Climacteric 4: 203\u2013208.","DOI":"10.1080\/cmt.4.3.203.208"},{"key":"10.1124\/jpet.105.091587_bib39","doi-asserted-by":"crossref","unstructured":"Vos RME, Krebbers SFM, Verhoeven CHJ, and Delbressine LPC (2002) The in vivo human metabolism of tibolone. Drug Metab Dispos 30: 106\u2013112.","DOI":"10.1124\/dmd.30.2.106"},{"key":"10.1124\/jpet.105.091587_bib40","doi-asserted-by":"crossref","unstructured":"Wang J, Chai X, Eriksson U, and Napoli JL (1999) Activity of human 11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and expression of its mRNA in extra-ocular human tissue. Biochem J 338: 23\u201327.","DOI":"10.1042\/bj3380023"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652432556X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652432556X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.091587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:47:53Z","timestamp":1740001673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652432556X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S002235652432556X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.091587","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tibolone Metabolism in Human Liver Is Catalyzed by 3\u03b1\/3\u03b2-Hydroxysteroid Dehydrogenase Activities of the Four Isoforms of the Aldo-Keto Reductase (AKR)1C Subfamily","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.091587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}